共查询到20条相似文献,搜索用时 10 毫秒
1.
Miha Sustersic Miha Mrak Polona Svegl Anamarija Rebolj Kodre Igor Kranjec Zlatko Fras Matjaz Bunc 《Global Heart》2021,16(1)
Background:Complete revascularization (CR) of ST-elevation myocardial infarction patients with multivessel coronary artery disease (MVD) has proven better regarding combined endpoints than incomplete revascularization (IR) in recent randomized control trials with no impact on survival.Objective:To retrospectively evaluate the impact of complete CR during the index hospitalization on survival in STEMI patients with MVD.Methods and results:We included all patients with MVD who underwent successful primary percutaneous coronary intervention for STEMI during their index hospitalization at the University Medical Centre Ljubljana, Slovenia (from 1 January 2009 to 3 April 2011). Coronary angiograms were reviewed for non-culprit coronary arteries (>2 mm in diameter and ≥50% stenosis) treated with percutaneous coronary intervention. Rates of all-cause and cardiovascular death were compared between 235 patients who underwent CR (N = 70) or IR (N = 165). After a median follow-up of 7.0 years (interquartile range 6.0–8.2) the CR group had lower rates of all-cause death (15.7% vs 35.8%, log-rank p = 0.003) and cardiovascular death (12.9% vs 23.6%, log-rank p = 0.046). Multivariable analysis with adjustment for confounders showed no benefit of CR for all-cause death (hazard ratio [HR] 0.60, 95% confidence interval [CI] 0.31–1.18, p = 0.139) or cardiovascular death (HR 0.80, 95% CI 0.37–1.72, p = 0.560). Age, elevated serum creatinine at inclusion, diabetes and cardiogenic shock at presentation were predictors of death.Conclusions:Patients with STEMI and MVD who underwent CR showed lower all-cause and cardiovascular death during follow-up than those who underwent IR. However, after adjustment for confounders, the real determinates of survival were independent of the revascularization method. 相似文献
2.
3.
Background Off-pump coronary artery bypass grafting (CABG) is becoming increasingly popular world - wide. But it is not always feasible. Current cardioplegic techniques do not consistently avoid myocardial ischemic damage. So we use on pump beating heart technique to supplement off-pump CABG. Methods Based on 860 off-pump CABG cases between Aug 1998 to Aug 2000. From Aug 1999 to Aug 2000, 46 CABG cases were performed with on pump beating heart technique at Mani-pal Hospital Heart Foundation, Bangalore, India. All surgeries were performed through a median sternotomy. Exposure techniques were tailored to individual vessels and cardiac regions and local immobilization was performed with octopus. Vascular control was achieved with occluders and shunts. Total cardiopulmonary bypass (CPB) was established before or during CABG and normolthemia was used. Results Among 46 on -pump beating heart CABG patients, 26 patients used CPB before or during OP - CABG because of unstable hemodynamics and electric instabilit 相似文献
4.
5.
Daniel Y. Lu Ming Zhong Dmitriy N. Feldman 《Current treatment options in cardiovascular medicine》2018,20(5):41
Purpose of review
In ST-segment elevation myocardial infarction, urgent revascularization of the culprit coronary vessel and restoration of coronary flow is the goal of the initial management. However, obstructive non-culprit disease is frequently concomitantly found during initial angiography and portends a poor prognosis. Management of non-culprit lesions in ST-segment elevation myocardial infarction (STEMI) has been the subject of extensive debate. This review will examine the currently available evidence, with a specific focus on randomized clinical trials performed to date.Recent findings
Although early observational data suggested better outcomes with culprit-only revascularization, more recent data from several randomized trials have suggested improved outcomes with complete multivessel revascularization, either during the index PCI procedure or as a staged procedure.Summary
Data from recent randomized controlled trials have suggested the superiority of complete or multivessel revascularization and have subsequently led to changes to the most recent iterations of STEMI guidelines. However, the optimal management and timing of revascularization of non-culprit lesions in STEMI remain controversial.6.
Theseverityofcomplicationassociatedwithcoronaryarterygrafting(CABG)bycardiopulmonarybypassarelegion犤1犦.Cardiopulmonarybypassandcar-dioplegicarrestareinanyofthemselvesnonphysiologicandinflictatotal-bodyinvasion,Pathophysiologicchangesoccurfromsyst 相似文献
7.
8.
高龄冠心病患者完全和不完全血运重建对疗效的影响 总被引:7,自引:0,他引:7
目的:评价高龄冠心病患者进行完全和不完全血运重建的近期与远期疗效.方法:对2000年1月至2003年3月期间收入我院经冠状动脉造影诊断为冠心病[(即以冠状动脉任何一支血管狭窄≥50%为诊断标准),高龄(年龄≥75岁),并接受经皮冠状动脉介入治疗(PCI,PCI组)]的患者75例和冠状动脉旁路移植术(CABG,CABG组)治疗的患者55例.随访6~38个月,平均(17.5±8.8)个月,分别观察冠状动脉血运重建完全与不完全的近期与远期疗效.结果:PCI组和CABG组从近期终点事件发生情况看:血运重建完全者与血运重建不完全者比较,近期死亡、急性心肌梗死和急诊CABG的发生率没有显著性差异(P>0.05);从远期终点事件发生情况看:血运重建完全者与血运重建不完全者比较,远期死亡、急性心肌梗死和再次血运重建的发生率以及心绞痛复发情况也没有显著性差异(P>0.05).结论:高龄患者的血运重建治疗虽然难以实现完全的血运重建,但是由于老年人的活动量小,尤其是高龄患者,只需对引起症状的大血管进行血运重建,远期效果良好. 相似文献
9.
Comparison of Complete and Incomplete Revascularization by Coronary Angioplasty for Unstable Angina 总被引:1,自引:0,他引:1
ROY S. SMALL M.D. DAVID R. HOLMES Jr M.D. RONALD E. VLIETSTRA M.B. Ch.B. GUY S. REEDER M.D. JOHN F. BRESNAHAN M.D. DENNIS R. BRESNAHAN M. D. 《Journal of interventional cardiology》1988,1(1):11-17
When a "culprit lesion" can be identified in a patient with unstable angina, it may be possible to achieve clinical improvement with incomplete revascularization. We analyzed actuarial survival free of an event (severe angina, myocardial infarction, coronary artery bypass graft, or death) at 6, 12, 18, and 24 months in 83 patients with multi-vessel disease and unstable angina who had undergone successful percutaneous transluminal coronary angioplasty (PTCA); revascularization was complete in 31 patients and incomplete in 52. Event-free survival in 85 patients with single-vessel disease and unstable angina who had undergone successful PTCA also was analyzed. Event-free survival at 24 months was worse in the multivessel disease patients than in the single-vessel disease patients (62% vs 85%; P = 0.001). Multivessel disease patients with complete revascularization had the same event-free survival as those with incomplete revascularization (63% vs 61%; P NS). Diagnostic angiograms revealed thrombus or an irregular ulcerated lesion in 42 of the multivessel disease patients. The event-free survival of these 42 patients was not different from that of the multivessel disease patients as a whole (64% vs 60%; P NS). We conclude that in patients with multivessel disease and unstable angina the event-free survival after PTCA is poorer than in patients with single-vessel disease and unstable angina. In the former patients, event-free survival does not necessarily depend on the completeness of revascularization. The outcome of patients who have intra-coronary thrombus or an irregular ulcerated lesion resembles the outcome of patients who lack these findings. (J Interven Cardiol: 1988:1:1) 相似文献
10.
《JACC: Cardiovascular Interventions》2022,15(24):2490-2502
BackgroundFunctional complete revascularization (FCR) after percutaneous coronary intervention (PCI) as determined by the residual functional SYNTAX score (rFSS) based on pressure wire fractional flow reserve assessment has been associated with an improved prognosis.ObjectivesThis study sought to determine the rates and clinical implications of FCR as assessed by the quantitative flow ratio (QFR), and to determine the outcomes of pre-PCI QFR guidance compared with standard angiography guidance in patients achieving and not achieving FCR after PCI.MethodsIn the randomized, sham-controlled, blinded, multicenter FAVOR (Comparison of Quantitative Flow Ratio Guided and Angiography Guided Percutaneous Intervention in Patients with Coronary Artery Disease) III China trial, QFR-guided PCI reduced the 1-year rate of major adverse cardiac events (MACE) compared with angiography-guided PCI. In the present prespecified substudy, the incidence of MACE was compared according to the presence of post-PCI FCR (rFSS = 0 based on core laboratory–assessed QFR) in the QFR-guided and angiography-guided groups.ResultsAmong 3,781 patients with available rFSS assessments, 3,221 (85.2%) achieved FCR, including 88.1% after QFR guidance and 82.2% after angiography guidance (P < 0.001). Patients with FCR had a markedly lower rate of 1-year MACE compared with those with functional incomplete revascularization (FIR) (rFSS ≥1) (5.1% vs 19.7%; P < 0.001). Prognostic models including the rFSS had higher discrimination and reclassification ability than those with the anatomic residual SYNTAX score. The relative risks for 1-year MACE with QFR-guided compared with the angiography-guided lesion selection were consistent in patients achieving FCR (4.1% vs 6.3%; HR: 0.65; 95% CI: 0.47-0.88) and in those with FIR (18.7% vs 20.4%; HR: 0.90; 95% CI: 0.61-1.32) (Pinteraction = 0.19).ConclusionsIn this large-scale trial, achieving FCR after PCI was associated with markedly lower 1-year rates of MACE. Compared with standard angiography guidance, QFR-guided PCI lesion selection improved the likelihood of achieving FCR and improved 1-year clinical outcomes in patients with both FCR and FIR. 相似文献
11.
《JACC: Cardiovascular Interventions》2020,13(13):1557-1567
ObjectivesThe aim of this study was to evaluate the long-term outcomes of patients with acute coronary syndromes (ACS) with multivessel disease undergoing percutaneous coronary intervention (PCI).BackgroundControversy exists regarding the benefit of multivessel PCI across the spectrum of ACS.MethodsA total of 9,094 patients with ACS and multivessel disease (≥70% stenosis in 2 or more major epicardial vessels) undergoing PCI from the Alberta COAPT (Contemporary Acute Coronary Syndrome Patients Invasive Treatment Strategies) registry (April 1, 2007, to March 31, 2013) were reviewed. Comparisons were made between patients who underwent complete revascularization and those with incomplete revascularization. Complete revascularization was defined as multivessel PCI with a residual angiographic jeopardy score ≤10%. Associations between revascularization status and all-cause death or new myocardial infarction (primary composite endpoint) and all-cause death, new myocardial infarction, or repeat revascularization (secondary composite endpoint) were evaluated.ResultsOf the study cohort, 66.0% underwent complete revascularization. Compared with incomplete revascularization, the primary composite endpoint occurred less frequently with complete revascularization (event rate within 5 years 15.4% vs. 22.2%; inverse probability-weighted hazard ratio [IPW-HR]: 0.78; 95% confidence interval [CI]: 0.73 to 0.84; p < 0.0001). The secondary composite endpoint was less likely to occur with complete revascularization (event rate within 5 years 23.3% vs. 37.5%; IPW-HR: 0.61; 95% CI: 0.58 to 0.65; p < 0.0001). Complete revascularization was associated with a reduction in all-cause death (IPW-HR: 0.79; 95% CI: 0.73 to 0.86; p = 0.0004), new myocardial infarction (IPW-HR: 0.76; 95% CI: 0.69 to 0.84; p < 0.0001), and repeat revascularization (IPW-HR: 0.53; 95% CI: 0.49 to 0.57; p < 0.0001).ConclusionsResults from this large contemporary registry of patients with ACS and PCI for multivessel disease suggest that complete revascularization occurs commonly and is associated with improved clinical outcomes (including survival) within 5 years. 相似文献
12.
13.
PIOTR WACINSKI M.D. PHILIP URBAN M.D. PASCAL CHATELAIN M.D. CAROLINE BACCHIOCCHI-SUILEN M.D. JOSE RAMOS DE OLIVAL M.D. PIERRE-ANDRÉ DORSAZ Ph.D. 《Journal of interventional cardiology》1999,12(5):349-353
Background: Although availability of stents has made percutaneous transluminal coronary angioplasty (PTCA) safer, single vessel angioplasty still represents 90% of procedures performed today. We report our initial experience with single session triple vessel angioplasty, using stents as needed to improve suboptimal balloon results. Patients: Fourteen patients (12 men, 85%), aged 67 ± 19 years were treated. All had triple vessel disease and angina. Mean left ventricular ejection fraction was 61%± 8%. Results: PTCA was attempted in all three coronaries or one of their major branches during the same procedure. Seventeen target lesions were in the left anterior descending coronary artery, 2 in a diagonal branch, 11 in the left circumflex, 2 in a marginal branch, 13 in the right coronary artery, 3 in the posterior descending, and 1 a saphenous vein graft. PTCA of 3.5 ± 0.7 sites/procedure was attempted. The success rate was 13 (93%) of 14 patients and 47 (96%) of 49 lesions. Thirty-four (69%) lesions were treated by implantation of one or several stents, and 10 (71%) of 14 patients received at least one stent. Hospital stay duration was 4 ± 2 days. One patient required repeat PTCA to treat subacute stent thrombosis 2 days after the procedure (creatine kinase [CK] peak < 2 times upper limit of normal). There were no in-hospital deaths, Q-wave infarction, or need for coronary artery bypass grafting (CABC). After a median follow-up period of 24 months (range 3–102), one (7%) patient had died of a noncardiac cause, three (21 %) had required repeat PTCA for restenosis in previously dilated lesions, and none had suffered a myocardial infarction. At follow-up, the median angina class was I (range I-II). Conclusion: For selected patients with three vessel disease, complete revascularization by single session PTCA and provisional stenting as needed is feasible, and is associated with a low rate of short- and long-term complications when successfully performed. 相似文献
14.
15.
16.
《The Canadian journal of cardiology》2019,35(8):1047-1057
BackgroundThe optimal strategy and timing of revascularization in hemodynamically stable patients with ST-segment elevation myocardial infarction and multivessel disease is unknown. We performed a systematic review and meta-analysis to explore the comparative efficacy and safety of early complete revascularization vs culprit-only or staged revascularization in this setting.MethodsWe searched the literature for randomized clinical trials that assessed this issue. Early complete revascularization was defined as a complete revascularization achieved during the index procedure or within 72 hours. Efficacy outcomes were major adverse cardiovascular events, myocardial infarction, repeat revascularization, and all-cause mortality. Safety outcomes were all bleeding events, stroke, and contrast-induced acute kidney injury.ResultsNine randomized clinical trials with a total of 2837 patients were included; 1254 received early complete revascularization and 1583 were treated with other revascularization strategies. After a mean follow-up of 15.3 ± 9.4 months early complete revascularization was associated with a lower risk of major adverse cardiovascular events (relative risk [RR], 0.51; 95% confidence interval [CI], 0.41-0.62; P < 0.00001; number needed to treat = 8), myocardial infarction (RR, 0.59; 95% CI, 0.40-0.87), and repeat revascularization (RR, 0.39; 95% CI, 0.28-0.55) without any difference in all-cause mortality and in safety outcomes compared with culprit-only or staged revascularization. Moreover, fractional flow reserve-guided complete revascularization reduced the incidence of repeat revascularization compared with angiography-guided procedure (χ2 = 4.36; P = 0.04).ConclusionsEarly complete revascularization should be considered in hemodynamically stable patients with ST-segment elevation myocardial infarction and multivessel disease deemed suitable for percutaneous interventions. Fractional flow reserve-guided complete revascularization might be superior to angiography-guided procedures in reducing need for further interventions. 相似文献
17.
Hüseyin Sürücü M.D. Ersan Tatl M.D. † Selnur Okudan M.D. Meryem Aktoz M.D. † 《Echocardiography (Mount Kisco, N.Y.)》2009,26(2):203-210
Objective: We aim to evaluate subepicardial and subendocardial left ventricular (LV) functions in patient single coronary artery lesion at early stage after percutaneous coronary intervention (PCI). Additionally, a comparison of LV functions between patients and control cases was aimed. Method: Patients with culprit left anterior descending (LAD) lesion (n = 25) and subjects with normal coronary angiography (n = 25) were evaluated. Patients underwent PCI and at least one coronary stent was placed. After PCI, the pulsed-wave tissue Doppler imaging (pw-TDI) parameters taken from subepicardial and subepicardial layers were compared among the patients. Results: Left atrium (P = 0.050), LV end-diastolic (P = 0.049), and end-systolic (P = 0.006) diameters were larger compared to the control group. LV inflow velocities were not different between the patient and the control group. But, the myocardial performance index was different (P = 0.049). The systolic and diastolic pw-TDI parameters were apparently different between the patient and the control group. While the systolic pw-TDI parameters did not change, the diastolic pw-TDI parameters taken from both subepicardial (circumferential contraction) and subendocardial layers (longitudinal contraction) improved after PCI. After PCI, it was shown that while Ea velocity (P = 0.012) taken from the subendocardial layer increased, IVRa velocity (P < 0.001) taken from the subepicardial layer decreased. Conclusion: In our study, it could be said that LV, left atrium, and aortic valve diameter increase in patients with coronary artery disease. The systolic and diastolic functions were impaired at subendocardial and subepicardial layers. These dysfunctions can be easily presented with pw-TDI. Although systolic dysfunction persists, diastolic dysfunction improves at early stage after PCI. 相似文献
18.
19.
《Cardiovascular Revascularization Medicine》2020,21(5):684-691
BackgroundPercutaneous coronary intervention (PCI) is the treatment of choice for ST-elevation myocardial infarction (STEMI). However, efficacy of complete vs culprit only revascularization in patients with STEMI and multivessel disease remains unclear.MethodsWe searched PubMed/MEDLINE, and Cochrane library. The primary endpoint was major adverse cardiovascular events (MACE). Secondary outcomes were all-cause mortality, cardiovascular mortality, myocardial infarction (MI), repeat revascularization, stroke, major bleeding, and contrast induced nephropathy. Estimates were calculated as random effects hazard ratios (HRs) with 95% confidence intervals (CI).ResultsTwelve trials with 7592 patients were included. There was a significantly lower risk of MACE [HR 0.61; 95% CI (0.43–0.60); p = 0.0009; I2 = 72%], cardiovascular mortality [HR 0.74; 95% CI (0.56–0.99); p = 0.04; I2 = 2%], and repeat revascularization [HR 0.43; 95% CI (0.31–0.59); p < 0.00001; I2 = 67%] in patients treated with complete compared with culprit-only revascularization. There was no statistically significant difference in MI [HR 0.77; 95% CI (0.52–1.12); p = 0.17; I2 = 49%], all-cause mortality [HR 0.86; 95% CI (0.65–1.13); p = 0.28; I2 = 14%], heart failure [HR 0.82 95% CI (0.51–1.32); p = 0.42; I2 = 26%], major bleeding [HR 1.07; 95% CI (0.66–1.75); p = 0.78; I2 = 25%], stroke [HR 0.67; 95% CI (0.24–1.89); p = 0.45; I2 = 54%], or contrast induced nephropathy, although higher contrast volumes were used in the complete revascularization group [HR 1.22; 95% CI (0.78–1.92); p = 0.39; I2 = 0%].ConclusionComplete revascularization was associated with a significantly lower risk of MACE, cardiovascular mortality, and repeat revascularization compared with culprit-only revascularization. These results suggest complete revascularization with PCI following STEMI and multivessel disease should be considered. 相似文献